{"id":"https://openalex.org/W82416764","doi":null,"title":"Safety profile of interferon-alpha therapy.","display_name":"Safety profile of interferon-alpha therapy.","alternate_titles":[],"publication_year":1998,"publication_date":"1998-02-01","ids":{"openalex":"https://openalex.org/W82416764","mag":"82416764","pmid":"https://pubmed.ncbi.nlm.nih.gov/9482535"},"language":"en","primary_location":{"id":"pmid:9482535","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9482535","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in oncology","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W82416764"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"K Weiss","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"K Weiss","raw_affiliation_strings":["Division of Clinical Trials Design and Analysis, Food and Drug Administration, Rockville, MD 20892, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Trials Design and Analysis, Food and Drug Administration, Rockville, MD 20892, USA","institution_ids":["https://openalex.org/I1320320070"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1320320070"],"apc_list":null,"apc_paid":null,"fwci":9.6541,"has_fulltext":false,"cited_by_count":92,"citation_normalized_percentile":{"value":0.99146439,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"25","issue":"1 Suppl 1","first_page":"9","last_page":"13"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.7720000147819519,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.7720000147819519,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.0737999975681305,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.023800000548362732,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interferon-alpha","display_name":"interferon-alpha","score":0.9570000171661377},{"id":"https://openalex.org/keywords/interferon-alfa-2a","display_name":"interferon alfa-2a","score":0.7940000295639038},{"id":"https://openalex.org/keywords/interferon-alpha-2b","display_name":"interferon alfa-2b","score":1.0},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.8169999718666077},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6000000238418579},{"id":"https://openalex.org/keywords/flu-like-symptoms","display_name":"flu-like symptoms","score":0.7749999761581421},{"id":"https://openalex.org/keywords/fatigue","display_name":"fatigue","score":0.7929999828338623},{"id":"https://openalex.org/keywords/anorexia","display_name":"anorexia","score":0.9739999771118164},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.656000018119812},{"id":"https://openalex.org/keywords/chronic-fatigue-syndrome","display_name":"chronic fatigue syndrome","score":0.6899999976158142},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8029999732971191},{"id":"https://openalex.org/keywords/post-marketing-surveillance","display_name":"post-marketing surveillance","score":0.703000009059906},{"id":"https://openalex.org/keywords/hairy-cell-leukemia","display_name":"hairy cell leukemia","score":0.7860000133514404},{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.8949999809265137},{"id":"https://openalex.org/keywords/kaposi-sarcoma","display_name":"Kaposi's sarcoma","score":0.8889999985694885},{"id":"https://openalex.org/keywords/hepatitis","display_name":"hepatitis","score":0.9120000004768372}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9356348514556885},{"id":"https://openalex.org/C2909179924","wikidata":"https://www.wikidata.org/wiki/Q6046488","display_name":"Alpha interferon","level":3,"score":0.7506705522537231},{"id":"https://openalex.org/C2778654693","wikidata":"https://www.wikidata.org/wiki/Q254327","display_name":"Anorexia","level":2,"score":0.748228907585144},{"id":"https://openalex.org/C2781228144","wikidata":"https://www.wikidata.org/wiki/Q6046441","display_name":"Interferon alfa","level":4,"score":0.6280071139335632},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.596027672290802},{"id":"https://openalex.org/C2776960273","wikidata":"https://www.wikidata.org/wiki/Q729735","display_name":"Chronic myelogenous leukemia","level":3,"score":0.5738143920898438},{"id":"https://openalex.org/C2777982462","wikidata":"https://www.wikidata.org/wiki/Q2481887","display_name":"Adjuvant therapy","level":3,"score":0.4615353047847748},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.45457524061203003},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.4161060154438019},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3792960047721863},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.35700711607933044},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.3524664342403412},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.285927951335907}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014486","descriptor_name":"United States Food and Drug Administration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D016907","descriptor_name":"Adverse Drug Reaction Reporting Systems","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:9482535","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9482535","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in oncology","raw_type":"Journal Article"},{"id":"mag:82416764","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9482535","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2415904695","https://openalex.org/W2048227276","https://openalex.org/W2108964272","https://openalex.org/W2029852331","https://openalex.org/W2159847907","https://openalex.org/W1986730863","https://openalex.org/W1573788741","https://openalex.org/W2574522608","https://openalex.org/W1792389655","https://openalex.org/W3175649011"],"abstract_inverted_index":{"Two":[0],"forms":[1],"of":[2,20,59,96,105,129],"recombinant":[3],"interferon-alpha":[4],"(IFN-alpha2a":[5,36],"and":[6,14,38,51,85,89,113,124],"IFN-alpha2b)":[7],"have":[8],"been":[9,101],"approved":[10],"by":[11],"the":[12,94,126],"Food":[13],"Drug":[15],"Administration":[16],"for":[17,41],"a":[18],"variety":[19],"clinical":[21,49],"indications,":[22],"including":[23],"hairy":[24],"cell":[25],"leukemia,":[26],"hepatitis,":[27],"acquired":[28],"immunodeficiency":[29],"syndrome-related":[30],"Kaposi's":[31],"sarcoma,":[32],"chronic":[33,110],"myelogenous":[34],"leukemia":[35],"only),":[37,44],"adjuvant":[39],"therapy":[40,65,79,131],"melanoma":[42],"(IFN-alpha2b":[43],"based":[45],"on":[46],"their":[47],"proven":[48],"efficacy":[50],"acceptable":[52],"safety":[53],"profiles.":[54],"The":[55,71],"continued":[56],"postmarketing":[57],"monitoring":[58],"adverse":[60,74],"reactions":[61],"associated":[62,76],"with":[63,77],"IFN-alpha":[64,78,130],"has":[66,98],"revealed":[67],"some":[68],"new":[69],"toxicities.":[70],"most":[72],"common":[73],"events":[75],"are":[80,132],"flu-like":[81],"symptoms,":[82],"fatigue,":[83,111],"anorexia,":[84,112],"central":[86],"nervous":[87],"system":[88],"psychiatric":[90],"reactions.":[91],"In":[92],"particular,":[93],"incidence":[95],"depression":[97],"only":[99],"recently":[100],"fully":[102],"appreciated.":[103],"Some":[104],"these":[106],"side":[107,127],"effects,":[108],"particularly":[109],"neuropsychiatric":[114],"reactions,":[115],"may":[116],"become":[117],"dose":[118],"limiting.":[119],"New":[120],"approaches":[121],"to":[122],"minimize":[123],"manage":[125],"effects":[128],"needed.":[133]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W82416764","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
